If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWYG Regulatory News (WYG)

  • There is currently no data for WYG

Form 8 (OPD) - WYG Plc

3 Feb 2015 07:00

RNS Number : 8367D
WYG Plc
03 February 2015
 



FORM 8 (OPD)

 

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

WYG plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

-

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

WYG plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

3 February 2015

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of 0.1 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

TOTAL:

Nil

0

Nil

0

 

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Shares held by directors of WYG plc

 

Director

Number of WYG plc shares

Percentage of existing WYG plc Shares (66,985,706)

Paul Hamer

126,842

0.19%

Sean Cummins

15,144

0.02%

Mike McTighe

200,000

0.30%

David Jeffcoat

190,264

0.28%

Robert Barr

20,025

0.03%

 

 

(b) Directors' rights to subscribe to WYG plc shares

 

(i) Transformation Incentive Plan and Chairman's Matching Share Award 

 

Director

Transformation Incentive Plan (TIP) (Note 1)

Chairman's

Matching

Share Award (Note 2)

Vested

Not yet vested

Total

Vested

Not yet vested

Total

Paul Hamer

1,437,906

2,875,814

4,313,720

Sean Cummins

647,058

1,294,116

1,941,174

Graham Olver

647,058

1,294,116

1,941,174

Mike McTighe

287,581

575,162

862,743

500,000

500,000

 

Note 1

In accordance with the rules of the TIP, the Awards have been granted as a conditional allocation of Ordinary Shares with a nominal value exercise price and no shareholder rights will be conferred upon the awardholders until the Awards have vested and Ordinary Shares are acquired. Such vesting is subject to the achievement of the share price threshold targets for the Ordinary Shares shown in the table below. The vested Awards have not been exercised by the holders and, if not exercised, will expire on the tenth anniversary of the Award date. Any Awards that remain unvested will expire automatically on 12 July 2016.

Performance Threshold for TIP

(Ordinary Share price level for 25 consecutive trading days)

Percentage of Award vesting

£1.50 or above

100%

£1.25 or above

66.66%

£1.00 or above

33.33%

Less than £1.00

Nil

 

Note 2

A share matching arrangement, whereby the Chairman's investment of £100,000 in the Company's capital restructuring can be matched on a 2.5 to 1 basis after three years providing that the Chairman remains on the Board for this period.

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

3 February 2015

Contact name:

Benjamin Whitworth, Company Secretary

Telephone number:

+44 (0)113 219 2254

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEEAPAAEAASEFF
Date   Source Headline
7th Jun 201810:49 amRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSFinal Results
20th Apr 20187:00 amRNSHolding(s) in Company
19th Apr 20188:57 amRNSHolding(s) in Company
9th Apr 20188:25 amRNSDirector/PDMR Shareholding
6th Apr 20185:19 pmRNSDirector/PDMR Shareholding
28th Mar 20187:00 amRNSTrading Update and Notice of Results
3rd Jan 20184:29 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:31 pmRNSDirector/PDMR Shareholding
2nd Jan 201811:02 amRNSUpdate on cash receipts
21st Dec 20173:56 pmRNSHolding(s) in Company
5th Dec 20177:00 amRNSAppointment of Non-Executive Director
5th Dec 20177:00 amRNSHalf-year Report
28th Nov 20172:56 pmRNSHolding(s) in Company
24th Nov 20177:00 amRNSTrading Update
7th Nov 201710:56 amRNSHolding(s) in Company
27th Oct 20173:09 pmRNSDirector/PDMR Shareholding
10th Oct 20174:58 pmRNSDirector/PDMR Shareholding
26th Sep 20175:19 pmRNSHolding(s) in Company
26th Sep 20171:06 pmRNSPDMR Shareholding
25th Sep 20172:53 pmRNSTotal Voting Rights
21st Sep 20171:12 pmRNSResult of AGM
20th Sep 201712:15 pmRNSHolding(s) in Company
7th Sep 20179:20 amRNSPDMR Shareholding
6th Sep 201712:24 pmRNSHolding(s) in Company
25th Aug 20177:00 amRNSTrading Update and Notice of Results
19th Jul 20177:00 amRNSPublication of Annual Report and Accounts
7th Jul 20173:46 pmRNSGrant of Share Options
6th Jul 20176:04 pmRNSPDMR Shareholding
8th Jun 201711:53 amRNSDirector/PDMR Shareholding
7th Jun 20174:18 pmRNSDirector/PDMR Shareholding
6th Jun 20177:00 amRNSDirectorate Change
6th Jun 20177:00 amRNSFinal Results
2nd Jun 20177:00 amRNSContract Win
25th Apr 20175:22 pmRNSHolding(s) in Company
7th Apr 201712:28 pmRNSDirector/PDMR Shareholding
4th Apr 201710:00 amRNSNotification of Major Interest in Shares
4th Apr 201710:00 amRNSNotification of Major Interest in Shares
31st Mar 201712:37 pmRNSExercise of Share Options & Total Voting Rights
23rd Mar 20177:00 amRNSTrading Update and Notice of Results
9th Mar 20174:34 pmRNSNotification of Major Interest in Shares
27th Feb 20172:15 pmRNSHolding(s) in Company
30th Jan 20171:08 pmRNSNotification of Major Interest in Shares
30th Jan 20177:00 amRNSDirectorate Change
26th Jan 20177:00 amRNSEU-financed Contract Wins
24th Jan 201711:31 amRNSNotification of Major Interest in Shares
24th Jan 201711:23 amRNSTotal Voting Rights
9th Jan 201710:07 amRNSNotification of Major Interest in Shares
5th Jan 20175:02 pmRNSNotification of Major Interest in Shares
9th Dec 20163:12 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.